AMN Healthcare Services Inc AMN
34.56
0.00
0.00%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 12.8×
Follow AMN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.99 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.37 | 0.21 | 0.22 | 0.28 | |
P/FCF ratio |
2.89 | 1.01 | 2.62 | 3.38 | |
P/Operating CF |
(6.65) | 1.27 | 8.03 | 32.99 | |
P/B ratio |
1.70 | 1.00 | 0.95 | 1.16 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.48 | 0.26 | 0.49 | 0.57 | |
EV/EBITDA |
4.75 | 2.88 | 6.36 | 6.80 | |
EV/Operating CF |
3.49 | 1.21 | 4.97 | 5.78 | |
EV/FCF |
3.76 | 1.27 | 5.77 | 6.97 | |
Quick Ratio |
1.02 | 0.96 | 0.80 | 0.91 | |
Current Ratio |
1.13 | 1.09 | 0.94 | 1.05 | |
Net Debt/EBITDA |
6.25 | 1.19 | 16.17 | 9.10 | |
Debt/Assets |
31.43% | 28.51% | 36.63% | 39.59% | |
Debt/Equity |
1.00 | 1.04 | 1.19 | 1.31 | |
Asset Turnover |
1.50 | 1.37 | 1.21 | 1.13 | |
Operating CF/Net income |
(8.98) | 9.05 | (9.82) | 0.77 | |
Capex/Depreciation |
(0.27) | (0.20) | (0.21) | (0.20) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.89% | 15.85% | 20.33% | 21.84% | |
Intangible Assets out of Total Assets |
0.43 | 0.39 | 0.50 | 0.49 | |
Share Based Compensation of Revenue |
1.46% | 0.72% | 0.77% | 1.06% | |
Graham Net Nets |
(0.60) | (1.06) | (1.49) | (1.24) | |
Graham Number |
33.97 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
8.34% | (4.69%) | (15.80%) | (37.14%) | |
Free Cash Flow Yield |
34.59% | 98.76% | 38.24% | 29.57% | |
Revenue per Share |
17.25 | 35.43 | 19.42 | 16.43 | |
Operating CF per Share |
(4.87) | 14.46 | 1.96 | 0.59 | |
Capex per Share |
(0.23) | (0.19) | (0.21) | (0.20) | |
Free Cash Flow per Share |
(5.10) | 14.27 | 1.76 | 0.38 | |
Cash per Share |
9.27 | 14.41 | 0.88 | 1.36 | |
Shareholders Equity per Share |
19.00 | 18.32 | 16.67 | 16.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.00 | 18.32 | 16.67 | 16.69 | |
Free Cash Flow |
(198.97) | 555.21 | 67.63 | 14.76 | |
Working Capital |
98.77 | 92.33 | (32.24) | 28.16 | |
Capital Expenditures |
(9.04) | (7.25) | (7.95) | (7.91) | |
Net Current Asset Value |
(753.44) | (755.05) | (906.62) | (924.22) | |
EV/EBIT |
8.23 | 18.20 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
3.14% | 4.51% | (1.03%) | 4.62% | |
Price to Operating Income |
6.32 | 14.50 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
435.77 | 464.67 | 469.45 | 481.17 | |
Average Payables |
184.42 | 196.68 | 173.14 | 192.17 | |
Average Assets |
2,288.10 | 2,499.75 | 2,254.92 | 2,403.38 | |
Average Common Equity |
674.44 | 713.93 | 674.36 | 767.54 |
Columns are period end dates